All News

The Market Tightens

How was business in 2015? What do you see coming in 2016? Drug Topics' annual business outlook survey took your input and put it all together.

Drug Topics Voices

Posts, e-mails, comments, and letters from Drug Topics readers

There are “significant breaches” in safe practices associated with managing hospital patients with external ambulatory pumps, according to a new survey from the Institute for Safe Medication Practices (ISMP).

FDA recently issued a drug safety communication that the labels of sodium-glucose cotransporter-2 (SGLT2) inhibitors include the risks of ketoacidosis and serious urinary tract infections, which can lead to hospitalization.